| Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target L Peyrin-Biroulet, W Sandborn, BE Sands, W Reinisch, W Bemelman, ... Official journal of the American College of Gastroenterology| ACG 110 (9 …, 2015 | 1826 | 2015 |
| Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease FM Ruemmele, G Veres, KL Kolho, A Griffiths, A Levine, JC Escher, ... Journal of Crohn's and Colitis 8 (10), 1179-1207, 2014 | 1173 | 2014 |
| The burden of inflammatory bowel disease in Europe J Burisch, T Jess, M Martinato, PL Lakatos, ECCO-EpiCom Journal of Crohn's and Colitis 7 (4), 322-337, 2013 | 1145 | 2013 |
| Extraintestinal manifestations of inflammatory bowel disease SR Vavricka, A Schoepfer, M Scharl, PL Lakatos, A Navarini, G Rogler Inflammatory bowel diseases 21 (8), 1982-1992, 2015 | 847 | 2015 |
| The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease M Harbord, V Annese, SR Vavricka, M Allez, M Barreiro-de Acosta, ... Journal of Crohn's and Colitis 10 (3), 239-254, 2016 | 822 | 2016 |
| 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 2: surgical management and special situations P Gionchetti, A Dignass, S Danese, FJ Magro Dias, G Rogler, PL Lakatos, ... Journal of Crohn's and Colitis 11 (2), 135-149, 2017 | 791 | 2017 |
| Recent trends in the epidemiology of inflammatory bowel diseases: up or down? PL Lakatos World journal of gastroenterology: WJG 12 (38), 6102, 2006 | 728 | 2006 |
| European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis EF Stange, SPL Travis, S Vermeire, W Reinisch, K Geboes, ... Journal of Crohn's and Colitis 2 (1), 1-23, 2008 | 725 | 2008 |
| Geographical variability and environmental risk factors in inflammatory bowel disease SC Ng, CN Bernstein, MH Vatn, PL Lakatos, EV Loftus, C Tysk, ... Gut 62 (4), 630-649, 2013 | 664 | 2013 |
| Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies PL Lakatos, L Lakatos World journal of gastroenterology: WJG 14 (25), 3937, 2008 | 568 | 2008 |
| East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort J Burisch, N Pedersen, S Čuković-Čavka, M Brinar, I Kaimakliotis, ... Gut 63 (4), 588-597, 2014 | 566 | 2014 |
| ECCO guidelines on therapeutics in ulcerative colitis: medical treatment T Raine, S Bonovas, J Burisch, T Kucharzik, M Adamina, V Annese, ... Journal of Crohn's and Colitis 16 (1), 2-17, 2022 | 468 | 2022 |
| Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study L Lakatos, T Pandur, G David, Z Balogh, P Kuronya, A Tollas, PL Lakatos World Journal of Gastroenterology 9 (10), 2300, 2003 | 407 | 2003 |
| Infliximab reduces endoscopic, but not clinical, recurrence of Crohn’s disease after ileocolonic resection M Regueiro, BG Feagan, B Zou, J Johanns, MA Blank, M Chevrier, ... Gastroenterology 150 (7), 1568-1578, 2016 | 323 | 2016 |
| Hospitalisations and surgery in Crohn's disease CN Bernstein, EV Loftus, SC Ng, PL Lakatos, B Moum Gut 61 (4), 622-629, 2012 | 295 | 2012 |
| Smoking in inflammatory bowel diseases: good, bad or ugly? PL Lakatos, T Szamosi, L Lakatos World journal of gastroenterology: WJG 13 (46), 6134, 2007 | 295 | 2007 |
| Risk factors for ulcerative colitis–associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study L Lakatos, G Mester, Z Erdelyi, G David, T Pandur, M Balogh, S Fischer, ... Inflammatory bowel diseases 12 (3), 205-211, 2006 | 287 | 2006 |
| Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss inflammatory bowel disease cohort SR Vavricka, G Rogler, C Gantenbein, M Spoerri, M Prinz Vavricka, ... Inflammatory bowel diseases 21 (8), 1794-1800, 2015 | 277 | 2015 |
| ECCO position statement on the use of biosimilars for inflammatory bowel disease—an update S Danese, G Fiorino, T Raine, M Ferrante, K Kemp, J Kierkus, PL Lakatos, ... Journal of Crohn's and Colitis 11 (1), 26-34, 2017 | 267 | 2017 |
| Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002–2006 L Lakatos, LS Kiss, G David, T Pandur, Z Erdelyi, G Mester, M Balogh, ... Inflammatory bowel diseases 17 (12), 2558-2565, 2010 | 248 | 2010 |
Maria PappUniversity of Debrecen在 med.unideb.hu 的电子邮件经过验证
